| Primary |
| Ill-defined Disorder |
57.9% |
| Drug Use For Unknown Indication |
21.9% |
| Hypertension |
7.4% |
| Product Used For Unknown Indication |
3.4% |
| Cardiac Failure Congestive |
1.9% |
| Prophylaxis |
1.7% |
| Cardiac Failure |
0.7% |
| Depression |
0.6% |
| Essential Hypertension |
0.6% |
| Drug Exposure During Pregnancy |
0.6% |
| Type 2 Diabetes Mellitus |
0.6% |
| Hypertensive Cardiomyopathy |
0.5% |
| Atrial Fibrillation |
0.4% |
| Myocardial Infarction |
0.4% |
| Nasopharyngitis |
0.4% |
| Coronary Artery Disease |
0.3% |
| Epilepsy |
0.3% |
| Hypercholesterolaemia |
0.3% |
| Anaemia |
0.2% |
| Angina Pectoris |
0.2% |
|
| Renal Failure Acute |
13.9% |
| Hyperkalaemia |
8.3% |
| Urinary Retention |
6.9% |
| Orthostatic Hypotension |
5.6% |
| Renal Failure |
5.6% |
| Respiratory Distress |
5.6% |
| Sciatica |
5.6% |
| Urinary Tract Infection |
5.6% |
| Ventricular Fibrillation |
5.6% |
| Pulmonary Oedema |
4.2% |
| Somnolence |
4.2% |
| Therapeutic Agent Toxicity |
4.2% |
| Toxic Skin Eruption |
4.2% |
| Weight Decreased |
4.2% |
| Abnormal Behaviour |
2.8% |
| Acute Pulmonary Oedema |
2.8% |
| Angina Pectoris |
2.8% |
| Dysphagia |
2.8% |
| Eczema |
2.8% |
| Jaundice |
2.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.2% |
| Hypertension |
19.8% |
| Product Used For Unknown Indication |
17.6% |
| Ill-defined Disorder |
5.7% |
| Angina Pectoris |
4.0% |
| Type 2 Diabetes Mellitus |
3.4% |
| Diabetes Mellitus |
2.8% |
| Hypercholesterolaemia |
2.5% |
| Prophylaxis |
1.8% |
| Back Pain |
1.7% |
| Cardiac Disorder |
1.5% |
| Dyslipidaemia |
1.3% |
| Myocardial Infarction |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Gastritis Prophylaxis |
1.2% |
| Atrial Fibrillation |
1.1% |
| Premedication |
1.1% |
| Acute Coronary Syndrome |
1.0% |
| Hiv Infection |
1.0% |
| Cardiac Failure |
0.9% |
|
| Renal Failure Acute |
16.9% |
| Vomiting |
10.8% |
| Toxic Skin Eruption |
7.7% |
| Renal Failure |
6.7% |
| Jaundice |
5.6% |
| Hyponatraemia |
5.1% |
| Liver Function Test Abnormal |
5.1% |
| Thrombocytopenia |
5.1% |
| Urticaria |
4.6% |
| Pancreatitis Acute |
4.1% |
| Colitis Ischaemic |
3.6% |
| Fall |
3.6% |
| Vascular Purpura |
3.6% |
| Pruritus |
3.1% |
| Rales |
3.1% |
| Orthostatic Hypotension |
2.6% |
| Shock |
2.6% |
| Angioedema |
2.1% |
| Neutropenia |
2.1% |
| Pyrexia |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.1% |
| Hypertension |
18.1% |
| Product Used For Unknown Indication |
16.8% |
| Rheumatoid Arthritis |
5.5% |
| Prophylaxis |
4.0% |
| Atrial Fibrillation |
3.7% |
| Diabetes Mellitus |
3.0% |
| Cardiac Failure |
2.9% |
| Hiv Infection |
2.8% |
| Depression |
2.6% |
| Osteoporosis |
2.6% |
| Pain |
2.3% |
| Crohn's Disease |
2.1% |
| Hypercholesterolaemia |
1.9% |
| Type 2 Diabetes Mellitus |
1.7% |
| Thrombosis Prophylaxis |
1.6% |
| Non-small Cell Lung Cancer |
1.5% |
| Acute Coronary Syndrome |
1.4% |
| Psoriasis |
1.4% |
| Asthma |
1.2% |
|
| Vomiting |
11.4% |
| Thrombocytopenia |
9.6% |
| Renal Failure |
9.1% |
| Renal Failure Acute |
6.7% |
| Myocardial Infarction |
6.5% |
| Pyrexia |
6.2% |
| Weight Decreased |
5.3% |
| Weight Increased |
4.5% |
| International Normalised Ratio Increased |
4.2% |
| Fall |
3.8% |
| Rhabdomyolysis |
3.8% |
| Pain In Extremity |
3.6% |
| Syncope |
3.6% |
| Ventricular Tachycardia |
3.6% |
| Nausea |
3.1% |
| Oedema Peripheral |
3.1% |
| Rash |
3.1% |
| Somnolence |
3.1% |
| Cytolytic Hepatitis |
2.9% |
| Hyponatraemia |
2.9% |
|
| Interacting |
| Ill-defined Disorder |
43.5% |
| Drug Use For Unknown Indication |
19.6% |
| Hypertension |
10.9% |
| Localised Infection |
5.4% |
| Cardiomyopathy |
4.3% |
| Cardiac Failure |
3.3% |
| Essential Hypertension |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Ankylosing Spondylitis |
1.1% |
| Arthralgia |
1.1% |
| Blood Cholesterol |
1.1% |
|
| Nitritoid Crisis |
17.6% |
| Drug Interaction |
11.8% |
| Hyperkalaemia |
11.8% |
| Renal Failure Acute |
11.8% |
| Somnolence |
11.8% |
| Blood Creatinine Increased |
5.9% |
| Pain In Extremity |
5.9% |
| Stent Placement |
5.9% |
| Urticaria |
5.9% |
| Ventricular Tachycardia |
5.9% |
| Vomiting |
5.9% |
|
